Want to see AU:1AI full AI Analyst Report?
Total Valuation
Living Cell Technologies has a market cap or net worth of AU$18.25M. The enterprise value is AU$14.24.
Market CapAU$18.25M
Enterprise ValueAU$14.24
Share Statistics
Living Cell Technologies has 2,027,571,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,027,571,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Living Cell Technologies’s return on equity (ROE) is -0.64 and return on invested capital (ROIC) is -64.56%.
Return on Equity (ROE)-0.64
Return on Assets (ROA)-0.61
Return on Invested Capital (ROIC)-64.56%
Return on Capital Employed (ROCE)-0.74
Revenue Per Employee0.00
Profits Per Employee-56.47K
Employee Count48
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Living Cell Technologies is ―. Living Cell Technologies’s PEG ratio is 0.00.
PE Ratio―
PS Ratio0.00
PB Ratio4.16
Price to Fair Value4.16
Price to FCF-6.81
Price to Operating Cash Flow-5.62
PEG Ratio0.00
Income Statement
In the last 12 months, Living Cell Technologies had revenue of 0.00 and earned -2.71M in profits. Earnings per share was >-0.01.
Revenue0.00
Gross Profit0.00
Operating Income-3.14M
Pretax Income-3.10M
Net Income-2.71M
EBITDA-3.14M
Earnings Per Share (EPS)>-0.01
Cash Flow
In the last 12 months, operating cash flow was -702.90K and capital expenditures -3.00, giving a free cash flow of -702.90K billion.
Operating Cash Flow-702.90K
Free Cash Flow-702.90K
Free Cash Flow per Share>-0.01
Dividends & Yields
Living Cell Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.17
52-Week Price Change0.00%
50-Day Moving Average0.01
200-Day Moving Average0.01
Relative Strength Index (RSI)42.07
Average Volume (3m)535.25K
Important Dates
Living Cell Technologies upcoming earnings date is Mar 3, 2027, TBA (Confirmed).
Last Earnings DateAug 27, 2026
Next Earnings DateMar 3, 2027
Ex-Dividend Date―
Financial Position
Living Cell Technologies as a current ratio of 25.11, with Debt / Equity ratio of 0.00%
Current Ratio25.11
Quick Ratio24.09
Debt to Market Cap0.00
Net Debt to EBITDA1.01
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Living Cell Technologies has paid -384.47K in taxes.
Income Tax-384.47K
Effective Tax Rate0.12
Enterprise Valuation
Living Cell Technologies EV to EBITDA ratio is -4.63, with an EV/FCF ratio of -5.59.
EV to Sales0.00
EV to EBITDA-4.63
EV to Free Cash Flow-5.59
EV to Operating Cash Flow-5.59
Balance Sheet
Living Cell Technologies has AU$1.88M in cash and marketable securities with AU$0.00 in debt, giving a net cash position of AU$1.88M billion.
Cash & Marketable SecuritiesAU$1.88M
Total DebtAU$0.00
Net CashAU$1.88M
Net Cash Per Share<AU$0.01
Tangible Book Value Per Share<AU$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Living Cell Technologies is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-200.00%